← Back to Search

"Liberal O2" for Respiratory Depression

N/A

Waitlist Available

Led By Anthony Doufas, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up forty minutes of monitoring for each treatment arm

Awards & highlights

Study Summary

This trial will explore how oxygen can help people recover from anesthesia more quickly. #medicine

Eligible Conditions

Respiratory Depression
Respiratory Failure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ forty minutes of monitoring for each treatment arm

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~forty minutes of monitoring for each treatment arm

This trial's timeline: 3 weeks for screening, Varies for treatment, and forty minutes of monitoring for each treatment arm for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Respiratory disturbance index (RDI)

Transcutaneous carbon dioxide pressure (TcPCO2)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: "Liberal O2"Experimental Treatment1 Intervention

During the second treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 > 96%.

Group II: "Conservative O2"Active Control1 Intervention

During the first treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 between 90% and 94%.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,334,040 Total Patients Enrolled

1 Trials studying Respiratory Depression

80 Patients Enrolled for Respiratory Depression

Anthony Doufas, MD, PhDPrincipal InvestigatorProfessor, Department of Anesthesiology, Stanford University Medical School

2 Previous Clinical Trials

68 Total Patients Enrolled

Media Library

"Liberal O2" Clinical Trial Eligibility Overview. Trial Name: NCT05922020 — N/A

Respiratory Depression Research Study Groups: "Conservative O2", "Liberal O2"

Respiratory Depression Clinical Trial 2023: "Liberal O2" Highlights & Side Effects. Trial Name: NCT05922020 — N/A

"Liberal O2" 2023 Treatment Timeline for Medical Study. Trial Name: NCT05922020 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile meet the criteria to partake in this medical trial?

"Eligibility criteria for this research stipulates that participants have respiratory depression and must be between 20-90 years old. 10 candidates are required in total."

Answered by AI

Is the minimum age criterion for this trial below 25 years?

"Those hoping to be accepted for this clinical trial must fall between the ages of 20 and 90. There are 33 studies that accept participants younger than 18 years old, and 168 trials recruiting those who are over 65."

Answered by AI

Is this trial presently seeking participants?

"The clinical trial registry at clinicaltrials.gov does not have this study listed as actively recruiting patients; it was initially announced on July 15th, 2023 and subsequently updated on June 27th, 2023. Despite the current inactivity of this medical research project, 193 other similar studies are presently accepting participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Hyperoxia on Ventilation During Recovery From General Anesthesia

Anthony Doufas 2023. "Hyperoxia on Ventilation During Recovery From General Anesthesia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05922020.